p.143 抽出テキスト
333. Natsuaki M, Morimoto T, Yamaji K, et al. CREDO ‐ Kyoto PCI/ CABG Registry Cohort 2, RESET, and NEXT trial investigators. Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO-Kyoto Thrombotic and Bleeding Risk Scores. J Am Heart Assoc 2018; 7: e008708. PMID: 29789335 334. Hess CN, Hiatt WR. Antithrombotic Therapy for Peripheral Artery Disease in 2018. JAMA 2018; 319: 2329-2330. PMID: 29860284 335. Sirimarco G, Amarenco P, Labreuche J, et al. REACH Registry Investigators. Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis. Stroke 2013; 44: 373- 379. PMID: 23306325 336. Ahmed B, Al-Khaffaf H. Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: A meta-analysis. Eur J Vasc Endovasc Surg 2009; 37: 262-271. PMID: 19058982 337. Razzouk L, Rockman CB, Patel MR, et al. Co-existence of vascular disease in different arterial beds: Peripheral artery disease and carotid artery stenosis --Data from Life Line Screening®. Atherosclerosis 2015; 241: 687-691. PMID: 26122189 338. Collet JP, Cayla G, Ennezat PV, et al. AMERICA Investigators. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study. Int J Cardiol 2018; 254: 36-42. PMID: 29407124 339. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2014; 31: 517-573. PMID: 25127426 340. Grenon SM, Vittinghoff E, Owens CD, et al. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: Insights from the Heart and Soul Study. Vasc Med 2013; 18: 176-184. PMID: 23835937 341. Subherwal S, Bhatt DL, Li S, et al. Polyvascular disease and longterm cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Qual Outcomes 2012; 5: 541-549. PMID: 22715460 342. Nakamura Y, Kunii H, Yoshihisa A, et al. Impact of peripheral artery disease on prognosis in hospitalized heart failure patients. Circ J 2015; 79: 785-793. PMID: 25739573 343. Kim EK, Song PS, Yang JH, et al. Peripheral artery disease in korean patients undergoing percutaneous coronary intervention: Prevalence and association with coronary artery disease severity. J Korean Med Sci 2013; 28: 87-92. PMID: 23341717 344. Hussein AA, Uno K, Wolski K, et al. Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol 2011; 57: 1220-1225. PMID: 21371639 345. Bonaca MP, Bhatt DL, Storey RF, et al. Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease. J Am Coll Cardiol 2016; 67: 2719-2728. PMID: 27046162 346. Saw J, Bhatt DL, Moliterno DJ, et al. The influence of peripheral arterial disease on outcomes: A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol 2006; 48: 1567-1572. PMID: 17045889 347. Miura T, Soga Y, Doijiri T, et al. Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention. Circ J 2013; 77: 89-95. PMID: 23018634 348. Aboyans V, Lacroix P, Postil A, et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2005; 46: 815-820. PMID: 16139130 349. Cacoub PP, Bhatt DL, Steg PG, et al. CHARISMA Investigators. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 2009; 30: 192-201. PMID: 19136484 350. Hlatky MA, Boothroyd DB, Baker L, et al. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: A cohort study. Ann Intern Med 2013; 158: 727-734. PMID: 23609014 351. Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013; 381: 639-650. PMID: 23439103 352. Dencker D, Pedersen F, Engstrøm T, et al. Major femoral vascular access complications after coronary diagnostic and interventional procedures: A Danish register study. Int J Cardiol 2016; 202: 604- 608. PMID: 26447671 353. Neufang A, Dorweiler B, Espinola-Klein C, et al. Outcomes of com- plex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J Vasc Surg 2014; 60: 1543-1553. PMID: 25238725 354. Spronk S, White JV, Ryjewski C, et al. Invasive treatment of claudi- cation is indicated for patients unable to adequately ambulate during cardiac rehabilitation. J Vasc Surg 2009; 49: 1217-1225. PMID: 19394551 355. Hur DJ, Kizilgul M, Aung WW, et al. Frequency of coronary artery disease in patients undergoing peripheral artery disease surgery. Am J Cardiol 2012; 110: 736-740. PMID: 22633203 356. Ishihara T, Iida O, Tosaka A, et al. Severity of coronary artery disease affects prognosis of patients with peripheral artery disease. Angiology 2013; 64: 417-422. PMID: 22773383 357. Cho I, Chang HJ, Sung JM, et al. CONFIRM Investigators. Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: An international multicenter registry). Circulation 2012; 126: 304-313. PMID: 22685117 358. Bhatt DL, Peterson ED, Harrington RA, et al. CRUSADE Investigators. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J 2009; 30: 1195- 1202. PMID: 19339264 359. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172-1181. PMID: 9027521 360. Ramos R, García-Gil M, Comas-Cufí M, et al. Statins for prevention of cardiovascular events in a low-risk population with low ankle brachial index. J Am Coll Cardiol 2016; 67: 630-640. PMID: 26868687 361. Sorber R, Alshaikh HN, Nejim B, et al. Quantifying the risk-adjusted hospital costs of postoperative complications after lower extremity bypass in patients with claudication. J Vasc Surg 2021; 73: 1361- 1367. PMID: 32931872 362. The Japanese Society For Vascular Surgery Jclimb Committee, Ncd Jclimb Analytical Team. Aggregated Data of JAPAN Critical Limb Ischemia Database (JCLIMB) Annual Reports from 2013 to 2016. Ann Vasc Dis 2019; 12: 412-436. PMID: 31636759 363. Iida O, Soga Y, Takahara M, et al. Perioperative complications after aorto-iliac stenting: Associated factors and impact on follow-up cardiovascular prognosis. Eur J Vasc Endovasc Surg 2014; 47: 131- 138. PMID: 24611185 364. Sato K, Iida O, Takahara M, et al. Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions. J Vasc Surg 2015; 61: 1272- 1277. PMID: 25925540 365. Society for Vascular Surgery Lower Extremity Guidelines Writing Group. Conte MS, Pomposelli FB, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg 2015; 61: 2S-41S. PMID: 25638515 366. Fowkes FG, Price JF, Stewart MC, et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: A randomized controlled trial. JAMA 2010; 303: 841-848. PMID: 20197530 367. Alahdab F, Wang AT, Elraiyah TA, et al. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg 2015; 61 Suppl: 42S-53S. PMID: 25721066 368. Itoga NK, Minami HR, Chelvakumar M, et al. Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test. Vasc Med 2018; 23: 97-106. PMID: 29345540 369. McDermott MM. Ankle brachial index as a predictor of outcomes in peripheral arterial disease. J Lab Clin Med 1999; 133: 33-40. PMID: 10385479 370. Long J, Modrall JG, Parker BJ, et al. Correlation between ankle-brachial index, symptoms, and health-related quality of life in patients with peripheral vascular disease. J Vasc Surg 2004; 39: 723-727. PMID: 15071432 371. Szuba A, Oka RK, Harada R, et al. Limb hemodynamics are not predictive of functional capacity in patients with PAD. Vasc Med 2006; 11: 155-163. PMID: 17288121 372. Grenon SM, Chong K, Alley H, et al. Walking disability in patients with peripheral artery disease is associated with arterial endothelial function. J Vasc Surg 2014; 59: 1025-1034. PMID: 24423479 373. Cooke JP, Meng S. Vascular Regeneration in Peripheral Artery Disease. Arterioscler Thromb Vasc Biol 2020; 40: 1627-1634. PMID: 32434408 374. Wu WC, Mohler E 3rd, Ratcliffe SJ, et al. Skeletal muscle micro- vascular flow in progressive peripheral artery disease: Assessment